Retinitis Pigmentosa (RP)
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive degeneration of the retina, particularly the light-sensitive cells known as photoreceptors. These cells include the rods, which are responsible for night and peripheral vision, and the cones, which provide central vision and color perception.
RP often begins with difficulty seeing in dim light and gradually progresses to loss of peripheral vision. Although there is currently no cure for most forms of RP, advances in genetic testing, low vision rehabilitation, retinal implants, and emerging gene therapies are providing new hope for affected patients and families.
What Is the Retina?
The retina is the thin layer of nerve tissue lining the back of the eye. It converts light into signals that travel through the optic nerve to the brain.
Two major types of photoreceptors allow us to see:
- Rods: Responsible for night vision and peripheral vision
- Cones: Responsible for sharp central vision and color vision
In RP, these photoreceptor cells gradually lose function and eventually degenerate.
What Causes Retinitis Pigmentosa?
RP is caused by inherited genetic mutations that affect retinal function.
More than 80 different genes have been associated with RP.
Commonly involved genes include:
- RHO
- USH2A
- RPGR
- PRPF31
- PDE6B
- EYS
RP can be inherited in several ways:
Autosomal Dominant Inheritance
Only one altered copy of a gene is needed to cause disease.
Autosomal Recessive Inheritance
Two altered copies of a gene are required.
X-Linked Inheritance
The mutated gene is located on the X chromosome and often causes more severe disease in males.
In some patients, there is no known family history despite a genetic cause.
Symptoms of Retinitis Pigmentosa
Symptoms usually begin during childhood, adolescence, or early adulthood, although the age of onset varies widely.
Common symptoms include:
Night Blindness
Difficulty seeing in dim lighting is often one of the earliest symptoms.
Patients may notice:
- Trouble driving at night
- Difficulty moving through dark rooms
- Slow adaptation when transitioning from bright to dark environments
Peripheral Vision Loss
Gradual narrowing of the visual field can lead to "tunnel vision."
Patients may experience:
- Bumping into objects
- Difficulty navigating crowded environments
- Reduced awareness of side objects
Central Vision Changes
Central vision is often preserved until later stages but may eventually become affected.
Symptoms may include:
- Difficulty reading
- Trouble recognizing faces
- Reduced color vision
Sensitivity to Bright Light
Some patients report increased glare and discomfort in bright environments.
How Is RP Diagnosed?
A retina specialist can diagnose RP using a combination of clinical examination, imaging, and genetic testing.
Dilated Retinal Examination
Classic retinal findings may include:
- Bone spicule pigmentation
- Narrowed retinal blood vessels
- Waxy pallor of the optic nerve
Visual Field Testing
This test measures peripheral vision and helps monitor disease progression.
Optical Coherence Tomography (OCT)
OCT provides detailed images of retinal structure and can identify:
- Photoreceptor loss
- Macular edema
- Remaining retinal architecture
Electroretinography (ERG)
ERG measures the retina's electrical response to light.
Patients with RP often demonstrate reduced retinal function.
Genetic Testing
Genetic testing can:
- Confirm the diagnosis
- Identify the responsible mutation
- Clarify inheritance patterns
- Determine eligibility for clinical trials and gene therapies
Treatment for Retinitis Pigmentosa
Although there is no cure for most forms of RP, several treatments and supportive measures can improve quality of life and preserve function.
Genetic Counseling
Understanding the underlying mutation can help guide treatment decisions and family planning.
Low Vision Rehabilitation
Low vision specialists can provide:
- Magnification devices
- Adaptive technology
- Mobility training
- Educational resources
Treatment of Associated Conditions
Some patients develop complications such as:
- Cataracts
- Cystoid macular edema
These conditions may be treatable and can improve vision.
Gene Therapy
Gene therapy has become a reality for certain inherited retinal diseases.
Patients with specific genetic mutations may qualify for approved treatments or clinical trials.
Clinical Trials and Emerging Therapies
Research is rapidly advancing and includes:
- Additional gene therapies
- Gene editing technologies
- Stem cell therapies
- Neuroprotective agents
- Optogenetic treatments
- Retinal prosthetic technologies
Participation in clinical trials may be appropriate for selected patients.
What Is the Prognosis?
The course of RP varies greatly depending on the underlying genetic mutation.
Some patients experience slow progression over decades, while others lose vision more rapidly.
Many patients maintain useful central vision well into adulthood, although peripheral vision often declines over time.
Regular follow-up with specialists in inherited retinal disease is important to monitor progression and identify emerging treatment opportunities.
Living With Retinitis Pigmentosa
Living with RP often requires adaptation and support.
Helpful strategies include:
- Maintaining regular eye examinations
- Considering genetic testing
- Using low vision resources
- Seeking orientation and mobility training when needed
- Protecting the eyes from injury
- Staying informed about clinical trials and emerging therapies
Support organizations and patient advocacy groups can also provide valuable educational and emotional resources.
Frequently Asked Questions
Is retinitis pigmentosa inherited?
Yes. RP is a genetic condition that can be inherited in several different patterns, including autosomal dominant, autosomal recessive, and X-linked forms.
Will I become completely blind?
Not necessarily. The severity and progression of RP vary considerably. Many patients retain useful central vision for years or decades.
Is there a cure for retinitis pigmentosa?
Currently, there is no cure for most forms of RP. However, genetic testing, emerging gene therapies, and ongoing clinical trials are creating new treatment possibilities.
More Information
For additional patient information, visit the American Society of Retina Specialists Retinitis Pigmentosa Page.
References
- American Society of Retina Specialists (ASRS) – Retinitis Pigmentosa
- Foundation Fighting Blindness – Retinitis Pigmentosa
- National Eye Institute – Retinitis Pigmentosa
- EyeWiki – Retinitis Pigmentosa
- National Organization for Rare Disorders (NORD) – Retinitis Pigmentosa